Maryland State Retirement & Pension System’s Sarepta Therapeutics SRPT Stock Holding History

Maryland State Retirement & Pension System’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Sell	15,310 -4,233	-22%	-$80.1K	﹤0.01%	1256
2026 Q1	$425K	Hold	19,543	–	–	0.01%	928
2025 Q4	$421K	Buy	19,543 +1,263	+7%	+$26.6K	0.01%	928
2025 Q3	$352K	Buy	+18,280	New	+$326K	0.01%	1011
2025 Q2	–	Sell	-4,233	Closed	-$270K	–	1503
2025 Q1	$270K	Sell	4,233 -945	-18%	-$99.5K	0.01%	1286
2024 Q4	$630K	Hold	5,178	–	–	0.01%	917
2024 Q3	$647K	Sell	5,178 -1,877	-27%	-$259K	0.01%	911
2024 Q2	$1.11M	Buy	7,055 +401	+6%	+$51.5K	0.02%	622
2024 Q1	$780K	Hold	6,654	–	–	0.02%	810
2023 Q4	$642K	Hold	6,654	–	–	0.01%	958
2023 Q3	$807K	Hold	6,654	–	–	0.02%	727
2023 Q2	$762K	Hold	6,654	–	–	0.02%	798
2023 Q1	$917K	Buy	6,654 +265	+4%	+$34.4K	0.02%	664
2022 Q4	$828K	Buy	+6,389	New	+$740K	0.02%	664
2022 Q3	–	Sell	-6,389	Closed	-$479K	–	1203
2022 Q2	$479K	Hold	6,389	–	–	0.02%	983
2022 Q1	$499K	Hold	6,389	–	–	0.01%	1063
2021 Q4	$575K	Buy	6,389 +630	+11%	+$53.9K	0.02%	1002
2021 Q3	$516K	Hold	5,759	–	–	0.01%	1064
2021 Q2	$422K	Hold	5,759	–	–	0.01%	785
2021 Q1	$429K	Buy	+5,759	New	+$531K	0.01%	788

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Maryland State Retirement & Pension System's SRPT Position: Q2 2026 in Review

Maryland State Retirement & Pension System reduced its Sarepta Therapeutics (SRPT) stake by 22% in Q2 2026, selling an estimated $80.1K and leaving 15,310 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Maryland State Retirement & Pension System first reported a position in SRPT in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.11M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Maryland State Retirement & Pension System held 15,310 shares of Sarepta Therapeutics worth $275K as of Q2 2026.
Maryland State Retirement & Pension System sold 4,233 Sarepta Therapeutics shares in Q2 2026, an estimated $80.1K.
Sarepta Therapeutics made up ﹤0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1256 holding.
Maryland State Retirement & Pension System first reported a position in Sarepta Therapeutics in Q1 2021 and has held it in 20 quarters since.
Maryland State Retirement & Pension System's Sarepta Therapeutics position peaked at $1.11M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.